Dr. Marri Pradeep Kumar Publishes Anticancer Agents Research

Anurag University is pleased to recognise the research achievement of Dr. Marri Pradeep Kumar, Assistant Professor in the Department of Chemistry, on the publication of his paper 'Synthesis, Biological Evaluation, and Molecular Docking Studies of Aryl 1,3,4-Oxadiazole-Quinazoline Derivatives as Anticancer Agents' in Chemical Data Collections, a Q2 journal with an Impact Factor of 2.7.
The fight against cancer continues to drive intensive research into new chemical compounds that can selectively target and inhibit cancer cells. Dr. Pradeep Kumar's work focuses on designing and synthesising novel oxadiazole-quinazoline derivatives, evaluating their biological activity, and using molecular docking studies to understand how these molecules interact with their biological targets. This integrated approach, combining synthesis, biological testing, and computational modelling, represents the modern methodology of drug discovery and offers promising leads for the development of future anticancer therapies. Publication in a reputed international journal reflects the scientific value and rigour of the research.
This achievement highlights Anurag University's commitment to medicinal and pharmaceutical chemistry research that holds genuine potential for human health. The university congratulates Dr. Marri Pradeep Kumar on this promising contribution to anticancer drug discovery and celebrates his dedication to research that aims to make a real difference.
Written By
By AU Media Team
More Stories You Might Like

Student Leadership Takes Center Stage
Ms. Thehnaaz Fathima, III B.Tech – AI, has been selected as a Campus Ambassador for the TATA Imagination Challenge 2026, marking a significant student achievement.

Driving Intelligent Decisions with AI
Dr. N. Suresh Rao and Dr. B. V. V. Siva Prasad, CSE faculty members, have published research on an AI-driven decision support framework in a Scopus Q1 journal with a CiteScore of 3.4.


